Elisaviatris 2 mg - 0.035 mg coat. tabl.

Country: Belġju

Lingwa: Ingliż

Sors: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Ingredjent attiv:

Ethinylestradiol 0,035 mg; Cyproterone acetate 2 mg

Disponibbli minn:

Viatris GX BV-SRL

Kodiċi ATC:

G03HB01

INN (Isem Internazzjonali):

Cyproterone acetate; Ethinylestradiol

Dożaġġ:

2 mg - 0,035 mg

Għamla farmaċewtika:

Coated tablet

Kompożizzjoni:

Cyproterone acetate 2 mg; Ethinylestradiol 35 µg

Rotta amministrattiva:

Oral use

Żona terapewtika:

Cyproterone and Estrogen

Sommarju tal-prodott:

CTI code: 239181-09 - Pack size: 9 x 21 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 239181-07 - Pack size: 7 x 21 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 239181-08 - Pack size: 8 x 21 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 239181-05 - Pack size: 5 x 21 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 239181-06 - Pack size: 6 x 21 - Commercialisation status: YES - FMD code: 05099151910639 - CNK code: 2216208 - Delivery mode: Medical prescription; CTI code: 239181-03 - Pack size: 3 x 21 - Commercialisation status: YES - FMD code: 05099151910646 - CNK code: 2095404 - Delivery mode: Medical prescription; CTI code: 239181-04 - Pack size: 4 x 21 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 239181-01 - Pack size: 21 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 239181-12 - Pack size: 12 x 21 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 239181-02 - Pack size: 2 x 21 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 239181-10 - Pack size: 10 x 21 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 239181-11 - Pack size: 11 x 21 - Commercialisation status: NO - Delivery mode: Medical prescription

L-istatus ta 'awtorizzazzjoni:

Commercialised: Yes

Data ta 'l-awtorizzazzjoni:

2002-08-05